Exogenous surfactant therapy shows promise for treating neonatal respiratory distress syndrome (RDS). Combining natural and artificial surfactants, like DPPC and PG, improves lung function in premature infants.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: